Lanneau GS - Search Results

1

ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.

Herzog TJ, Hays JL, Barlin JN, Buscema J, Cloven NG, Kong LR, Tyagi NK, Lanneau GS, Long BJ, Marsh RL, Seward SM, Starks DC, Welch S, Moore KN, Konstantinopoulos PA, Gilbert L, Monk BJ, O'Malley DM, Chen X, Dalal R, Coleman RL, Sehouli J. Herzog TJ, et al. Among authors: lanneau gs. Future Oncol. 2023 Jul;19(23):1577-1591. doi: 10.2217/fon-2023-0246. Epub 2023 Jun 19. Future Oncol. 2023. PMID: 37334673 Free article.

2

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study.

Landrum LM, Java J, Mathews CA, Lanneau GS Jr, Copeland LJ, Armstrong DK, Walker JL. Landrum LM, et al. Among authors: lanneau gs jr. Gynecol Oncol. 2013 Jul;130(1):12-8. doi: 10.1016/j.ygyno.2013.04.001. Epub 2013 Apr 8. Gynecol Oncol. 2013. PMID: 23578540 Free PMC article.

3

Vulvar cancer in young women: demographic features and outcome evaluation.

Lanneau GS, Argenta PA, Lanneau MS, Riffenburgh RH, Gold MA, McMeekin DS, Webster N, Judson PL. Lanneau GS, et al. Am J Obstet Gynecol. 2009 Jun;200(6):645.e1-5. doi: 10.1016/j.ajog.2009.01.014. Epub 2009 Mar 16. Am J Obstet Gynecol. 2009. PMID: 19286150

4

Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.

Landrum LM, Moore KN, Myers TK, Lanneau GS Jr, McMeekin DS, Walker JL, Gold MA. Landrum LM, et al. Among authors: lanneau gs jr. Gynecol Oncol. 2009 Feb;112(2):337-41. doi: 10.1016/j.ygyno.2008.10.009. Epub 2008 Nov 28. Gynecol Oncol. 2009. PMID: 19041126

5

Cervical dysplasia among women over 35 years of age.

Moore KN, Bannon RJ, Lanneau GS, Zuna RE, Walker JL, Gold MA. Moore KN, et al. Among authors: lanneau gs. Am J Obstet Gynecol. 2008 Nov;199(5):471.e1-5. doi: 10.1016/j.ajog.2008.03.048. Epub 2008 May 19. Am J Obstet Gynecol. 2008. PMID: 18486088

6

Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.

Ju T, Lanneau GS, Gautam T, Wang Y, Xia B, Stowell SR, Willard MT, Wang W, Xia JY, Zuna RE, Laszik Z, Benbrook DM, Hanigan MH, Cummings RD. Ju T, et al. Among authors: lanneau gs. Cancer Res. 2008 Mar 15;68(6):1636-46. doi: 10.1158/0008-5472.CAN-07-2345. Cancer Res. 2008. PMID: 18339842

7

Pathologic findings and outcomes for octogenarians presenting with uterine malignancy.

Moore KN, Lanneau GS, Smith C, Lanneau M, Walker JL, Gold MA, Scott McMeekin D. Moore KN, et al. Among authors: lanneau gs. Gynecol Oncol. 2007 Sep;106(3):572-8. doi: 10.1016/j.ygyno.2007.05.028. Epub 2007 Jul 5. Gynecol Oncol. 2007. PMID: 17618678

8

A LEEP cervical conization is rarely indicated for a two-step discrepancy.

Lanneau GS, Skaggs V, Moore K, Stowell S, Zuna R, Gold MA. Lanneau GS, et al. J Low Genit Tract Dis. 2007 Jul;11(3):134-7. doi: 10.1097/01.lgt.0000265776.29173.e1. J Low Genit Tract Dis. 2007. PMID: 17596756

9

Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era.

Landrum LM, Lanneau GS, Skaggs VJ, Gould N, Walker JL, McMeekin DS, Gold MA. Landrum LM, et al. Among authors: lanneau gs. Gynecol Oncol. 2007 Sep;106(3):521-5. doi: 10.1016/j.ygyno.2007.04.029. Epub 2007 May 31. Gynecol Oncol. 2007. PMID: 17540438

10

Second trimester placental location as a predictor of an adverse pregnancy outcome.

Magann EF, Doherty DA, Turner K, Lanneau GS Jr, Morrison JC, Newnham JP. Magann EF, et al. Among authors: lanneau gs jr. J Perinatol. 2007 Jan;27(1):9-14. doi: 10.1038/sj.jp.7211621. Epub 2006 Nov 2. J Perinatol. 2007. PMID: 17080095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page